BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26827605)

  • 1. Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop.
    Sakellaropoulos T; Hur J; Melas IN; Guo EY; Alexopoulos L; Bohlooly M; Bai JP
    Adv Protein Chem Struct Biol; 2016; 102():147-79. PubMed ID: 26827605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
    Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
    Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Pac Symp Biocomput; 2016; 21():321-32. PubMed ID: 26776197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Text mining for precision medicine: automating disease-mutation relationship extraction from biomedical literature.
    Singhal A; Simmons M; Lu Z
    J Am Med Inform Assoc; 2016 Jul; 23(4):766-72. PubMed ID: 27121612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining the coding and non-coding genome for cancer drivers.
    Li J; Drubay D; Michiels S; Gautheret D
    Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.
    Thanintorn N; Wang J; Ersoy I; Al-Taie Z; Jiang Y; Wang D; Verma M; Joshi T; Hammer R; Xu D; Shin D
    Pac Symp Biocomput; 2016; 21():417-28. PubMed ID: 26776205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing, analysing, and integrating big data in medical bioinformatics: open problems and future perspectives.
    Merelli I; Pérez-Sánchez H; Gesing S; D'Agostino D
    Biomed Res Int; 2014; 2014():134023. PubMed ID: 25254202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioinformatics in Cancer Clinical Sequencing -- An Emerging Field of Cancer Personalized Medicine].
    Kato M
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):391-7. PubMed ID: 27220783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing Big Data in Cancer Care.
    Schlick CJR; Castle JP; Bentrem DJ
    Surg Oncol Clin N Am; 2018 Oct; 27(4):641-652. PubMed ID: 30213409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Text mining for traditional Chinese medical knowledge discovery: a survey.
    Zhou X; Peng Y; Liu B
    J Biomed Inform; 2010 Aug; 43(4):650-60. PubMed ID: 20074663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distant supervision for cancer pathway extraction from text.
    Poon H; Toutanova K; Quirk C
    Pac Symp Biocomput; 2015; ():120-31. PubMed ID: 25592574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature mining, ontologies and information visualization for drug repurposing.
    Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
    Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for the identification of driver mutations in cancer: A tutorial from a computational perspective.
    Cutigi JF; Evangelista AF; Simao A
    J Bioinform Comput Biol; 2020 Jun; 18(3):2050016. PubMed ID: 32698724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ConsensusDriver Improves upon Individual Algorithms for Predicting Driver Alterations in Different Cancer Types and Individual Patients.
    Bertrand D; Drissler S; Chia BK; Koh JY; Li C; Suphavilai C; Tan IB; Nagarajan N
    Cancer Res; 2018 Jan; 78(1):290-301. PubMed ID: 29259006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics.
    Lu DY; Qu RX; Lu TR; Wu HY
    Rev Recent Clin Trials; 2017; 12(2):101-110. PubMed ID: 28190390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational models for predicting drug responses in cancer research.
    Azuaje F
    Brief Bioinform; 2017 Sep; 18(5):820-829. PubMed ID: 27444372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer driver mutation prediction through Bayesian integration of multi-omic data.
    Wang Z; Ng KS; Chen T; Kim TB; Wang F; Shaw K; Scott KL; Meric-Bernstam F; Mills GB; Chen K
    PLoS One; 2018; 13(5):e0196939. PubMed ID: 29738578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.